Business Standard

Thursday, December 19, 2024 | 10:46 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

WHO seeks more info from Bharat Biotech for emergency listing of Covaxin

The documents showed Bharat Biotech submitted Expression of Interest with the WHO for emergency use listing (EUL) on April 19

Bharat Biotech, Covaxin
Premium

Photo: Shutterstock

BS Web Team New Delhi
The World Health Organization (WHO) has sought more information from Bharat Biotech on its emergency use listing (EUL) application for Covaxin, according to the documents on the global health agency's website.

The documents showed Bharat Biotech submitted Expression of Interest with the WHO for EUL on April 19.

Bharat Biotech will hold a pre-submission meeting with WHO in May or June. After the meeting, there are further three stages where the application will be reviewed before the approval.

The WHO’s EUL opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine. It also enables UNICEF

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in